Midostaurin is a new drug used for the treatment of:
Midostaurin : Multitargeted protein kinase inhibitor indicated along with standard cytarabine and daunorubicin for adult with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation positive.
JIPMER 2017
CML
ALL
AML
CLL
AML